Romiplostim for the treatment of chronic immune thrombocytopenia

Technology appraisal guidance
Reference number: TA221
Published: 27 April 2011
Last updated: 26 October 2018

Thrombocytopenic purpura - romiplostim: consultee and commentator comments on the ACD received from the Department of Health

Thrombocytopenic purpura - romiplostim: consultee and commentator comments on the ACD received from the Department of Health

Thrombocytopenic purpura - romiplostim: consultee and commentator comments on the ACD received from the Department of Health
17 March 2011
(67.83 Kb 19 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 March 2011